Product
CKD-391
1 clinical trial
1 indication
Indication
DyslipidemiaClinical trial
A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of CKD-391 and Co-administration of CKD-331 and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-02-27